Pneumasal 2.5mg Respules (2.5ml Each)

Pneumasal 2.5mg Respules (2.5ml Each) is a tablet-form medicine used for asthma attacks, exercise-induced asthma, COPD bronchospasm, bronchitis flare-ups. It works by stimulates beta-2 receptors in airways to relax bronchial muscles within minutes. Falling under the respiratory care category, it is commonly prescribed in India for respiratory and breathing disorder management. The active ingredient in Pneumasal 2.5mg Respules (2.5ml Each) is Salbutamol (2.5mg). Active ingredients are the components in a medicine that produce its intended therapeutic effect, and the same active ingredient may appear in many brand names across India at different price points. Pneumasal 2.5mg Respules (2.5ml Each) is manufactured and marketed in India by Pneumasal 2.5mg Respules (2.5ml Each). Like every medicine sold in India, it is regulated by the Central Drugs Standard Control Organisation (CDSCO) and must meet the quality standards specified in the Indian Pharmacopoeia. Pneumasal 2.5mg Respules (2.5ml Each) is supplied in a pack of 5 units. The current verified price through GoDavaii is approximately ₹27, which may vary slightly between pharmacies and cities. As a tablet-form medicine, Pneumasal 2.5mg Respules (2.5ml Each) should be stored, handled and used following the form-specific guidance below. Pneumasal 2.5mg Respules (2.5ml Each) is generally available without a prescription in India, but over-the-counter availability is not the same as risk-free use. Even OTC medicines can interact with other medicines, worsen underlying conditions, or be unsuitable in pregnancy, breastfeeding, kidney or liver disease - which is why a quick check with a qualified medical professional or with GoDavaii's AI is always sensible before starting any new medicine. Always use Pneumasal 2.5mg Respules (2.5ml Each) exactly as advised by a qualified medical professional. Do not exceed the recommended dose, do not extend the course beyond what is prescribed, and do not share the medicine with family members even if their symptoms appear similar.